MedPal AI plc logo

MedPal AI plc (Z1N)

Market Open
24 Aug, 20:00
XSTU XSTU
0. 04
0
0%
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
0.04
Previous Close
Add Transaction
Day Range
0.04 0.04
Year Range
0.01 0.09
Want to track Z1N and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

Z1N trading today higher at €0.04, an increase of 0% from yesterday's close, completing a monthly increase of 24.6377% or €0.01. Over the past 12 months, Z1N stock lost -12.2449%.
Z1N is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on XSTU (EUR).

Z1N Chart

MedPal AI plc (Z1N) FAQ

What is the stock price today?

The current price is €0.04.

On which exchange is it traded?

MedPal AI plc is listed on XSTU.

What is its stock symbol?

The ticker symbol is Z1N.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has MedPal AI plc ever had a stock split?

No, there has never been a stock split.

MedPal AI plc Profile

- Industry
- Sector
Mr. Jason Kingsley Drummond CEO
XSTU Exchange
- ISIN
United Kingdom Country
5 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

MedPal AI plc is a UK-based digital health company at the forefront of utilizing advanced artificial intelligence to enhance personal health management and empower individuals. The company operates a consumer-focused, non-clinical platform that aggregates health data from a vast array of wearable devices and mobile applications, including Apple Health, Fitbit, Garmin, and Google Fit. Through this integration, MedPal AI provides users with real-time, personalized insights, actionable recommendations, and proactive health monitoring via intelligent alerts. The platform is designed to foster proactive well-being tracking, bridging the gap between raw data and practical health guidance, while also delivering timely reminders for preventive care. MedPal AI places a strong emphasis on maintaining strict data privacy standards and adhering to modern regulatory requirements. Although the platform does not provide medical diagnoses or treatments, it supports holistic wellness initiatives and can facilitate connections with licensed healthcare professionals through integrated telehealth services. Recently, the company has expanded its strategic focus by acquiring assets in the rapidly growing GLP-1 agonist market for obesity treatment, signaling its intent to play a prominent role in the evolving digital health and wellness sector. As a public limited company headquartered in London, MedPal AI is listed domestically and offers international investors a unique opportunity to invest in AI-driven health innovation.

Products and Services

  • Health Data Aggregation Platform

    This core product collects and synthesizes health data from a multitude of devices and applications. By offering real-time insights and recommendations, it helps users make informed health decisions.

  • Personalized Health Insights

    MedPal AI provides users with tailored insights based on their aggregated health data. This feature enables individuals to understand their unique health patterns and receive guidance on improving well-being.

  • Proactive Health Monitoring

    The platform utilizes intelligent alerts to help users stay on top of their health. This service notifies users of potential health issues and encourages proactive management of their wellness.

  • Preventive Care Reminders

    Timely reminders for screenings and check-ups are integrated into the platform, promoting preventive care and helping users maintain optimal health status.

  • Telehealth Integration

    When necessary, users can escalate their concerns through the platform to connected healthcare professionals via telehealth services, ensuring they receive appropriate support and guidance.

  • Data Privacy Compliance

    MedPal AI is committed to upholding stringent data privacy standards and regulatory compliance, reassuring users that their personal health information is protected and secure.

  • Expanding Portfolio in GLP-1 Agonist Market

    The company's recent ventures into the GLP-1 agonist market for obesity treatment reflect its commitment to enhancing its product offerings and contributing to the fields of digital health and wellness.

Contact Information

Address: 71 Queen Victoria Street
Phone: 44 7400 800 500